In the BioHarmony Drug Report Database

"Preview" Icon

Danaparoid

Orgaran (danaparoid sodium) is an unknown pharmaceutical. Danaparoid sodium was first approved as Orgaran on 1996-12-24. It is used to treat pulmonary embolism, thrombocytopenia, thromboembolism, and venous thrombosis in the USA. The pharmaceutical is active against antithrombin-III.

 

Trade Name

 

Orgaran
 

Common Name

 

danaparoid sodium
 

ChEMBL ID

 

CHEMBL1201534
 

Indication

 

pulmonary embolism, thrombocytopenia, thromboembolism, venous thrombosis
 

Drug Class

 

Antithrombotics (heparinoid type)

Image (chem structure or protein)

Danaparoid structure rendering